News

March 3, 2014 — Biotronik announced the release of its Passeo-18 Lux drug-releasing balloon (DRB) in all countries...

Cordis Trieme Chocolate PTA Balloon Catheter Peripheral Artery Disease PAD

Cordis Corp. announced an agreement with TriReme Medical Inc. that grants the company exclusive distribution rights for the Chocolate PTA Balloon Catheter. 

balloon catheters peripheral artery disease intact vascular tack-it

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced the start of enrollment in the Tack Optimized ...

balloon catheters cath lab drug-eluting clinical trials angioscore angiosculpt

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease...

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

balloon catheters stents clinical trial study orbusneich scoreflex journal

OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s...

The global sales of drug-eluting balloons (DEBs) across the 10 major markets (10MM) are expected to witness a significant increase over the coming years, from $164m in 2012 to $477m in...

balloon catheters cath lab clinical trial study angioscore angiosculpt scoring

AngioScore Inc., a developer of angioplasty catheters for use in the treatment of cardiovascular...

Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters were the first devices used in the field of interventional cardiology. The growth of the stent market, which is the largest...

AngioScore AngioSculpt Drug-Coated Scoring Catheter FIH Study

AngioScore Inc. announced the completion of enrollment in the Drug-Coated AngioSculpt Scoring Balloon Catheter First-in-Human (FIH) Study (PATENT-C). AngioScore anticipates that preliminary data...

One-year data from an Italian multicenter randomized controlled trial of the In.Pact Falcon drug-eluting balloon from Medtronic Inc. demonstrate positive and durable clinical results with the...

June 25, 2013 — Cordis Corp. announced the European CE marking and U.S. Food and Drug Administration (FDA) approval of additional sizes of its Sleek OTW (over-the-wire) platform, a 0.014-inch...

Lutonix Drug Coated Balloon C. R. Bard Inc. PAD Treatments Clinical Trial

C. R. Bard Inc. announced the enrollment of the first patient into the Lutonix Below the Knee (BTK) Clinical Trial at The Cardiac and Vascular Institute in Gainesville, Fla. The purpose of this...

Covidien recently introduced its RapidCross 0.014-inch Rapid Exchange Percutaneous Transluminal Angioplasty (PTA) Balloon, which offers rapid exchange (RX) convenience with kink-resistant...

Boston Scientific, Apex, balloon catheter

The total U.S. market for PTCA and cutting balloon catheters was valued at $293.5 million in 2012. The PTCA balloon segment accounted for close to 90 percent of the total coronary balloon catheter...

 V8 Aortic Valvuloplasty Balloon Catheter InterValve

InterValve Inc. announced that it has received 510(k) clearance to market the new V8 Aortic Valvuloplasty Balloon Catheter in the United States.

 

balloon, CTO

Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires and balloon dilation catheters for...

AngioSculpt 10 mm Balloon Catheter PAD treatment

AngioScore Inc. announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

C-section Hysterectomy Clinical trial Interventional Radiology Balloon Catheter

Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while preventing hysterectomy and preserving...

December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first calendar quarter of 2013. Financial...